| scholarly article | Q13442814 |
| P2093 | author name string | A D O'Brien | |
| J E Samuel | |||
| S W Lindgren | |||
| C K Schmitt | |||
| P2860 | cites work | A rapid alkaline extraction procedure for screening recombinant plasmid DNA | Q24614998 |
| Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities | Q24646436 | ||
| Crystal structure of the cell-binding B oligomer of verotoxin-1 from E. coli | Q27644365 | ||
| Development of verotoxin 2- and verotoxin 2 variant (VT2v)-specific oligonucleotide probes on the basis of the nucleotide sequence of the B cistron of VT2v from Escherichia coli E32511 and B2F1 | Q40214420 | ||
| Quantitative microtiter cytotoxicity assay for Shigella toxin. | Q40230921 | ||
| Shiga-like toxin II-related cytotoxins in Citrobacter freundii strains from humans and beef samples | Q40373934 | ||
| Edema disease-like brain lesions in gnotobiotic piglets infected with Escherichia coli serotype O157:H7 | Q40426879 | ||
| Cloning and nucleotide sequence of a variant Shiga-like toxin II gene from Escherichia coli OX3:H21 isolated from a case of sudden infant death syndrome | Q48160670 | ||
| Relative colonizing abilities of human fecal and K 12 strains of Escherichia coli in the large intestines of streptomycin-treated mice. | Q54516989 | ||
| Reproduction of Edema Disease of Swine with Purified Shiga-like Toxin-II Variant | Q54703471 | ||
| Purification and some properties of a Vero toxin from Escherichia coli O157:H7 that is immunologically unrelated to Shiga toxin. | Q54763750 | ||
| Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. | Q54764104 | ||
| Purification and some properties of a Vero toxin from a human strain of Escherichia coli that is immunologically related to Shiga-like toxin II (VT2) | Q57563891 | ||
| Production of Shiga-Like Toxin by Escherichia coli | Q57563903 | ||
| Cloning and sequencing of a Shiga-like toxin II-related gene from Escherichia coli O157:H7 strain 7279 | Q68090249 | ||
| Globotetraosylceramide is recognized by the pig edema disease toxin | Q69517260 | ||
| Analysis of the antigenic difference between Vero toxin 2 (VT2) and VT2 variant (VT2vh) of Verotoxin-producing Escherichia coli by a site-directed mutagenesis | Q70178227 | ||
| Studies on transformation of Escherichia coli with plasmids | Q27860598 | ||
| Rapid and efficient site-specific mutagenesis without phenotypic selection | Q27860628 | ||
| The pathogenic mechanisms of Shiga toxin and the Shiga-like toxins | Q33376042 | ||
| Cloning and nucleotide sequencing of Vero toxin 2 variant genes from Escherichia coli O91:H21 isolated from a patient with the hemolytic uremic syndrome | Q33396788 | ||
| Continuous peritoneal infusion of Shiga-like toxin II (SLT II) as a model for SLT II-induced diseases | Q33426826 | ||
| Hemolytic uremic syndrome and diarrhea in Argentine children: the role of Shiga-like toxins | Q33428528 | ||
| Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157:H7 infections | Q33429817 | ||
| Hemolytic uremic syndrome and diarrhea associated with Escherichia coli O157:H7 in a day care center | Q33453248 | ||
| The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli | Q33457864 | ||
| Hemolytic-uremic syndrome associated with verotoxin-producing Escherichia coli | Q33457911 | ||
| Sporadic cases of hemorrhagic colitis associated with Escherichia coli O157:H7. | Q33477769 | ||
| Profile of Escherichia coli O157:H7 pathogen responsible for hamburger-borne outbreak of hemorrhagic colitis and hemolytic uremic syndrome in Washington | Q33493213 | ||
| Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice | Q33605233 | ||
| Virulence of enterohemorrhagic Escherichia coli O91:H21 clinical isolates in an orally infected mouse model | Q33608157 | ||
| Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. | Q34049372 | ||
| Molecular cloning and nucleotide sequence of another variant of the Escherichia coli Shiga-like toxin II family | Q34050888 | ||
| Vero response to a cytotoxin of Escherichia coli | Q34177128 | ||
| Hemorrhagic Colitis Associated with a RareEscherichia coliSerotype | Q34256166 | ||
| Functional analysis of the Shiga toxin and Shiga-like toxin type II variant binding subunits by using site-directed mutagenesis. | Q34372184 | ||
| Acute renal tubular necrosis and death of mice orally infected with Escherichia coli strains that produce Shiga-like toxin type II | Q35109009 | ||
| Escherichia coli cytotoxins and enterotoxins | Q35367741 | ||
| Cloning and sequencing of the genes for Shiga toxin from Shigella dysenteriae type 1. | Q36194407 | ||
| Cloning and sequencing of a Shiga-like toxin type II variant from Escherichia coli strain responsible for edema disease of swine | Q36215407 | ||
| Adherence and colonization mechanisms of enteropathogenic and enterohemorrhagic Escherichia coli. | Q36319476 | ||
| Properties of strains of Escherichia coli belonging to serogroup O157 with special reference to production of Vero cytotoxins VT1 and VT2 | Q36472567 | ||
| Alteration of the carbohydrate binding specificity of verotoxins from Gal alpha 1-4Gal to GalNAc beta 1-3Gal alpha 1-4Gal and vice versa by site-directed mutagenesis of the binding subunit | Q36785336 | ||
| Two copies of Shiga-like toxin II-related genes common in enterohemorrhagic Escherichia coli strains are responsible for the antigenic heterogeneity of the O157:H- strain E32511 | Q36974749 | ||
| Comparison of the glycolipid receptor specificities of Shiga-like toxin type II and Shiga-like toxin type II variants | Q36977977 | ||
| Mouse model for colonization and disease caused by enterohemorrhagic Escherichia coli O157:H7 | Q36986374 | ||
| Affinity purification and characterization of Shiga-like toxin II and production of toxin-specific monoclonal antibodies | Q36997934 | ||
| Shiga and Shiga-like toxins | Q37063416 | ||
| Isolation and characterization of monoclonal antibodies to Shiga-like toxin II of enterohemorrhagic Escherichia coli and use of the monoclonal antibodies in a colony enzyme-linked immunosorbent assay | Q37156797 | ||
| Identification of verotoxin type 2 variant B subunit genes in Escherichia coli by the polymerase chain reaction and restriction fragment length polymorphism analysis | Q37239269 | ||
| Identification of the carbohydrate receptor for Shiga toxin produced by Shigella dysenteriae type 1. | Q38349693 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Escherichia coli | Q25419 |
| cytotoxicity | Q246181 | ||
| P304 | page(s) | 623-631 | |
| P577 | publication date | 1994-02-01 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | The specific activities of Shiga-like toxin type II (SLT-II) and SLT-II-related toxins of enterohemorrhagic Escherichia coli differ when measured by Vero cell cytotoxicity but not by mouse lethality | |
| P478 | volume | 62 |
| Q37190873 | A DNA vaccine encoding the enterohemorragic Escherichia coli Shiga-like toxin 2 A2 and B subunits confers protective immunity to Shiga toxin challenge in the murine model |
| Q27622010 | A mutant Shiga-like toxin IIe bound to its receptor Gb(3): structure of a group II Shiga-like toxin with altered binding specificity |
| Q30940276 | A new family of potent AB(5) cytotoxins produced by Shiga toxigenic Escherichia coli |
| Q40409371 | A newly discovered verotoxin variant, VT2g, produced by bovine verocytotoxigenic Escherichia coli. |
| Q35487599 | Activation of Shiga-like toxins by mouse and human intestinal mucus correlates with virulence of enterohemorrhagic Escherichia coli O91:H21 isolates in orally infected, streptomycin-treated mice |
| Q36068651 | Affinity-Based Screening of Tetravalent Peptides Identifies Subtype-Selective Neutralizers of Shiga Toxin 2d, a Highly Virulent Subtype, by Targeting a Unique Amino Acid Involved in Its Receptor Recognition |
| Q38354498 | Aglycone modulation of glycolipid receptor function |
| Q33395264 | Antibody response to Shiga toxins in Argentinean children with enteropathic hemolytic uremic syndrome at acute and long-term follow-up periods |
| Q90131552 | Bimodal Response to Shiga Toxin 2 Subtypes Results from Relatively Weak Binding to the Target Cell |
| Q50571489 | Characterisation of Escherichia coli O157 isolates from Danish cattle and human patients by genotyping and presence and variants of virulence genes. |
| Q39822350 | Comparative toxicity and virulence of Escherichia coli clones expressing variant and chimeric Shiga-like toxin type II operons |
| Q34201747 | Detection in Escherichia coli of the genes encoding the major virulence factors, the genes defining the O157:H7 serotype, and components of the type 2 Shiga toxin family by multiplex PCR. |
| Q34595772 | Enhanced virulence of the Escherichia coli O157:H7 spinach-associated outbreak strain in two animal models is associated with higher levels of Stx2 production after induction with ciprofloxacin |
| Q33496795 | Enterobacter cloacae producing a Shiga-like toxin II-related cytotoxin associated with a case of hemolytic-uremic syndrome. |
| Q24604606 | Escherichia coli Subtilase Cytotoxin |
| Q36899078 | Identification and characterization of Shiga toxin type 2 variants in Escherichia coli isolates from animals, food, and humans |
| Q36401470 | Mass Spectrometry-Based Method of Detecting and Distinguishing Type 1 and Type 2 Shiga-Like Toxins in Human Serum |
| Q71785854 | Modelling of the interaction of verotoxin-1 (VT1) with its glycolipid receptor, globotriaosylceramide (Gb3) |
| Q35017672 | Molecular analysis of subtilase cytotoxin genes of food-borne Shiga toxin-producing Escherichia coli reveals a new allelic subAB variant |
| Q61810513 | Molecular epidemiology of sequence type 33 of Shiga toxin-producing O91:H14 isolates from human patients and retail meats in Korea |
| Q37256478 | Monoclonal antibody 11E10, which neutralizes shiga toxin type 2 (Stx2), recognizes three regions on the Stx2 A subunit, blocks the enzymatic action of the toxin in vitro, and alters the overall cellular distribution of the toxin. |
| Q34497115 | Mouse models of Escherichia coli O157:H7 infection and shiga toxin injection |
| Q34128036 | One of two copies of the gene for the activatable shiga toxin type 2d in Escherichia coli O91:H21 strain B2F1 is associated with an inducible bacteriophage |
| Q24550740 | Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections |
| Q36747071 | Pathogenesis of renal disease due to enterohemorrhagic Escherichia coli in germ-free mice |
| Q41129049 | Prevalence and distribution of the stx, stx genes in Shiga toxin producing E. coli (STEC) isolates from cattle. |
| Q40937787 | Prevalence of the stx2 gene in coliform populations from aquatic environments |
| Q35673972 | Reduced Toxicity of Shiga Toxin (Stx) Type 2c in Mice Compared to Stx2d Is Associated with Instability of Stx2c Holotoxin. |
| Q34491859 | Reduced virulence of an fliC mutant of Shiga-toxigenic Escherichia coli O113:H21. |
| Q27021676 | Shiga Toxin (Stx) Classification, Structure, and Function |
| Q36705833 | Shiga Toxin (Stx) Type 1a Reduces the Oral Toxicity of Stx Type 2a |
| Q41669177 | Shiga Toxin Therapeutics: Beyond Neutralization. |
| Q35558583 | Shiga toxin 2 subtypes of enterohemorrhagic E. coli O157:H- E32511 analyzed by RT-qPCR and top-down proteomics using MALDI-TOF-TOF-MS. |
| Q40954039 | Shiga toxin glycosphingolipid receptors of Vero-B4 kidney epithelial cells and their membrane microdomain lipid environment |
| Q34667008 | Shiga toxin of enterohemorrhagic Escherichia coli type O157:H7 promotes intestinal colonization. |
| Q37357868 | Shiga toxin type 2dact displays increased binding to globotriaosylceramide in vitro and increased lethality in mice after activation by elastase |
| Q28743696 | Specific egg yolk immunoglobulin as a new preventive approach for Shiga-toxin-mediated diseases |
| Q92153341 | Structural and Functional Characterization of Stx2k, a New Subtype of Shiga Toxin 2 |
| Q33808280 | The MAP kinase-activated protein kinase 2 (MK2) contributes to the Shiga toxin-induced inflammatory response |
| Q90347611 | The Virulence of Escherichia coli O157:H7 Isolates in Mice Depends on Shiga Toxin Type 2a (Stx2a)-Induction and High Levels of Stx2a in Stool |
| Q35105318 | Top-down proteomic identification of Shiga toxin 2 subtypes from Shiga toxin-producing Escherichia coli by matrix-assisted laser desorption ionization-tandem time of flight mass spectrometry |
| Q54590916 | Two distinct binding sites for globotriaosyl ceramide on verotoxins: identification by molecular modelling and confirmation using deoxy analogues and a new glycolipid receptor for all verotoxins. |
| Q40979852 | Verotoxins inhibit the growth of and induce apoptosis in human astrocytoma cells |
| Q40290677 | Virulence Potential of Activatable Shiga Toxin 2d-Producing Escherichia coli Isolates from Fresh Produce. |
Search more.